Fourth Vaccination Ups Immunity to Omicron Variants in Cancer Patients
Humoral response seen in patients receiving B cell-targeted therapy for hematologic malignancy, patients with solid malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.